Overview

A Safety,Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule

Status:
Recruiting
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety, tolerability and pharmacokinetic characteristics of JX11502MA capsule on healthy human, and to explore the relationship between the dose, pharmacokinetic parameters and safety of JX11502MA capsule,so as to provide basis for the follow-up clinical trials (multi-dose tolerability, pharmacokinetics and phase II trial, etc.).
Phase:
Phase 1
Details
Lead Sponsor:
Zhejiang Jingxin Pharmaceutical Co., Ltd.